Analyst Downgrades – ABIOMED (NASDAQ:ABMD) Stock Gets Downgraded By BTIG Research from Buy to Neutral

ME Staff
-
0

Analyst Ratings For ABIOMED (NASDAQ:ABMD)

Today, ABIOMED (NASDAQ:ABMD) stock was downgraded by BTIG Research from Buy to Neutral.

There are 2 hold ratings, 6 buy ratings on the stock.

The current consensus rating on ABIOMED (NASDAQ:ABMD) is Buy (Score: 2.75) with a consensus target price of $174.71 per share, a potential 2.48% upside.

Some recent analyst ratings include

  • 10/16/2017-BTIG Research was Downgraded by analysts at BTIG Research from a “Buy ” rating to a ” Neutral” rating.
  • 10/12/2017-Leerink Swann Reiterated Rating of Outperform.
  • 9/29/2017-SunTrust Banks, Inc. initiated coverage with a Buy rating.
  • 8/29/2017-Piper Jaffray Companies Reiterated Rating of Buy.
  • 7/10/2017-Morgan Stanley Reiterated Rating of Equal Weight.
  • 6/8/2017-William Blair Reiterated Rating of Outperform .

Recent Insider Trading Activity For ABIOMED (NASDAQ:ABMD)
ABIOMED (NASDAQ:ABMD) has insider ownership of 7.00% and institutional ownership of 89.37%.

  • On 10/2/2017 Andrew J Greenfield, VP, sold 11,282 with an average share price of $169.32 per share and the total transaction amounting to $1,910,268.24. View SEC Filing
  • On 8/30/2017 Eric A Md Rose, Director, sold 982 with an average share price of $145.17 per share and the total transaction amounting to $142,556.94. View SEC Filing
  • On 8/24/2017 Eric A Md Rose, Director, sold 23,018 with an average share price of $151.09 per share and the total transaction amounting to $3,477,789.62. View SEC Filing
  • On 8/15/2017 Paul Thomas, Director, sold 10,000 with an average share price of $154.71 per share and the total transaction amounting to $1,547,100.00. View SEC Filing
  • On 7/31/2017 David M Weber, COO, sold 16,500 with an average share price of $147.63 per share and the total transaction amounting to $2,435,895.00. View SEC Filing
  • On 5/16/2017 Michael G Howley, VP, sold 18,279 with an average share price of $133.56 per share and the total transaction amounting to $2,441,343.24. View SEC Filing
  • On 5/8/2017 David M Weber, COO, sold 21,250 with an average share price of $130.89 per share and the total transaction amounting to $2,781,412.50. View SEC Filing

Recent Trading Activity for ABIOMED (NASDAQ:ABMD)
Shares of ABIOMED closed the previous trading session at with shares trading hands.